Form 4 Filing for Celldex Therapeutics, Inc. - Stock Option Grant to Elizabeth Crowley

This filing details a stock option grant to Elizabeth Crowley, SR. VP & CPDO at Celldex Therapeutics, Inc. The grant, effective June 25, 2026, includes 100,000 Incentive Stock Options with a purchase price of $34.09 per share. The options vest starting June 25, 2027, with 25% vesting on that date and the remainder vesting quarterly over the subsequent 12 quarters. The options are granted under the company's 2021 Omnibus Equity Incentive Plan and expire on June 25, 2036. This transaction is classified as an acquisition of a derivative security.